The Collaborative of Eating Disorder Organizations wrote an open letter to the AAP, which said in part: "The statements throughout these guidelines are problematic at best, and at worst, put American children and adolescents at serious risk for developing eating disorders, disordered eating, and other mental and physical health issues." Bolling says hes unaware if there is a relationship between GLP-1 agonist medications and eating disorders but acknowledges more research needs to be done on this topic
The emerging science might not be the problem, but these peptides should be clearly labeled regarding the risks they pose
In adipose tissue G0S2 expression is very low during fasting but increases after feeding
Though the mechanisms through which this drug might influence alcohol craving and consumption are not known, in theory semaglutides inhibition of the appetitive centers in the brain could lead to reduced cravings and appetite for things other than food, like alcohol and other drugs
Is Multi+ a GLP-1 medication or a substitute for one